Cargando…

A novel model to predict cancer‐specific survival in patients with early‐stage uterine papillary serous carcinoma (UPSC)

OBJECTIVE: Stage I‐II uterine papillary serous carcinoma (UPSC) has aggressive biological behavior and leads to poor prognosis. However, clinicopathologic risk factors to predict cancer‐specific survival of patients with stage I‐II UPSC were still unclear. This study was undertaken to develop a pred...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Lihua, Liu, Xiaona, Li, Mengjiao, Wang, Shuoer, Zhou, Hongyu, Liu, Lei, Cheng, Xi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997089/ https://www.ncbi.nlm.nih.gov/pubmed/31846222 http://dx.doi.org/10.1002/cam4.2648

Ejemplares similares

Can morphometric analysis of the fallopian tube fimbria predict the presence of uterine papillary serous carcinoma (UPSC)?
por: Amit, Amnon, et al.
Publicado: (2019)

Postoperative chemotherapy had no prognostic effect on early‐staged young ovarian cancer with unilateral resection
por: Zhang, Xiaofei, et al.
Publicado: (2018)

Management of Women with Surgically Staged 1 Uterine Papillary Serous Cancer
por: Elit, Laurie, et al.
Publicado: (2011)

Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers
por: Hamilton, C A, et al.
Publicado: (2006)

Clinicopathological features, survival outcomes, and appropriate surgical approaches for stage I acinar and papillary predominant lung adenocarcinoma
por: Lu, Di, et al.
Publicado: (2020)

Clinicopathological Characteristics and Her-2/neu Status in Chinese Patients with Uterine Papillary Serous Carcinoma
por: Ren, Yulan, et al.
Publicado: (2011)

Discrimination between uterine serous papillary carcinomas and ovarian serous papillary tumours by gene expression profiling
por: Santin, A D, et al.
Publicado: (2004)

Comparison of Survival Benefits of Combined Chemotherapy and Radiotherapy Versus Chemotherapy Alone for Uterine Serous Carcinoma: A Meta-analysis
por: Lin, Yanying, et al.
Publicado: (2017)

Which is worse: uterine papillary serous carcinomas or carcinosarcomas?
por: Song, Taejong, et al.
Publicado: (2011)

Papillary Serous Carcinoma of the Uterine Cervix with Lung Metastasis
por: Khan, Maliha, et al.
Publicado: (2014)

Adrenal Metastasis from Uterine Papillary Serous Carcinoma
por: Lubana, Sandeep Singh, et al.
Publicado: (2016)

Metastatic papillary serous uterine cancer presenting as a rash
por: Chang, Eric S., et al.
Publicado: (2016)

Evaluation of adjuvant therapy in women with uterine papillary serous cancer
por: Al Husaini, Hamed, et al.
Publicado: (2012)

A methylomics‐associated nomogram predicts recurrence‐free survival of thyroid papillary carcinoma
por: Chen, Hengyu, et al.
Publicado: (2020)

Gene expression fingerprint of uterine serous papillary carcinoma: identification of novel molecular markers for uterine serous cancer diagnosis and therapy
por: Santin, A D, et al.
Publicado: (2005)

Spatial cytotoxic and memory T cells in tumor predict superior survival outcomes in patients with high‐grade serous ovarian cancer
por: Zhang, Guodong, et al.
Publicado: (2021)

Clinicopathological and survival analysis of uterine papillary serous carcinoma: a single institutional review of 106 cases
por: Wang, Yao, et al.
Publicado: (2018)

T-DM1, a novel antibody–drug conjugate, is highly effective against primary HER2 overexpressing uterine serous carcinoma in vitro and in vivo
por: English, Diana P, et al.
Publicado: (2014)

Cytologic Findings of Cervicovaginal Smears in Women with Uterine Papillary Serous Carcinoma
por: Park, Ji-Young, et al.
Publicado: (2005)

In vitro activity of pertuzumab in combination with trastuzumab in uterine serous papillary adenocarcinoma
por: El-Sahwi, K, et al.
Publicado: (2010)

Survival implication of lymphadenectomy in patients surgically treated for apparent early-stage uterine serous carcinoma
por: Casarin, Jvan, et al.
Publicado: (2020)

Trends in survival of patients with stage I/II Burkitt lymphoma in the United States: A SEER database analysis
por: Liu, Ze‐Long, et al.
Publicado: (2019)

Development and validation of a nomogram based on stromal score to predict progression‐free survival of patients with papillary thyroid carcinoma
por: Tang, Jiajia, et al.
Publicado: (2021)

Rare brain metastasis with unusual characteristics in a late recurrence of stage IIIA uterine papillary serous carcinoma
por: Crain, Charles Nicolas, et al.
Publicado: (2021)

Evaluating overall survival and competing risks of survival in patients with early‐stage breast cancer using a comprehensive nomogram
por: Xu, Yan‐Bo, et al.
Publicado: (2020)

Breast‐conserving therapy is associated with better survival than mastectomy in Early‐stage breast cancer: A propensity score analysis
por: Ji, Jiali, et al.
Publicado: (2022)

In search for biomarkers and potential drug targets for uterine serous endometrial cancer
por: Dinoi, Giorgia, et al.
Publicado: (2021)

Excellent Response to Palliative Chemotherapy for Pleural Recurrence of Uterine Papillary Serous Carcinoma
por: Singh, Shantanu, et al.
Publicado: (2013)

PLK3 amplification and tumor immune microenvironment of metastatic tumors are linked to adjuvant treatment outcomes in uterine serous cancer
por: Jones, Wendell, et al.
Publicado: (2022)

Clinicopathologic characteristics and survival analysis in stage IVB cervical cancer with hematogenous metastasis
por: Li, Haoran, et al.
Publicado: (2019)

Survival following radiotherapy in young women with localized early‐stage breast cancer according to molecular subtypes
por: Liu, Qi‐Qi, et al.
Publicado: (2019)

An miRNA signature associated with tumor mutation burden in endometrial cancer
por: Zhou, Hongyu, et al.
Publicado: (2020)

Serum amyloid A (SAA): a novel biomarker for uterine serous papillary cancer
por: Cocco, E, et al.
Publicado: (2009)

Improved survival of patients with hypermutation in uterine serous carcinoma
por: Santin, Alessandro D., et al.
Publicado: (2015)

The Genomic Landscape of Early-Stage Ovarian High-Grade Serous Carcinoma
por: Cheng, Zhao, et al.
Publicado: (2022)

Prognostic nomograms to predict overall survival and cancer‐specific survival in patients with pelvic chondrosarcoma
por: Chen, Li, et al.
Publicado: (2019)

Testicular papillary serous cystadenocarcinoma: a rare case report and review of the literature
por: Geramizadeh, Bita, et al.
Publicado: (2011)

Comprehensive subgroup analyses of survival outcomes between clear cell renal cell adenocarcinoma and papillary renal cell adenocarcinoma
por: Huang, Jingyi, et al.
Publicado: (2020)

Assessment of the VENUSS and GRANT Models for Individual Prediction of Cancer-specific Survival in Surgically Treated Nonmetastatic Papillary Renal Cell Carcinoma
por: Piccinelli, Mattia L., et al.
Publicado: (2023)

Nomogram for predicting overall survival in stage II‐III colorectal cancer
por: Liu, Jungang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lpo539mu1nrrm2gjpt35ps2lm8